01:32Biosimilars: a cheaper yet equally efficient alternative to name-brand medications
From the creator
The European Commission's pharmaceutical reform would improve access to cheaper biosimilar medicines and speed up the time it takes to access the market. In partnership with The European Commission READ MORE : https://www.euronews.com/2023/10/19/biosimilars-a-cheaper-yet-equally-efficient-alternative-to-name-brand-medications Euronews Next is a future-focused news section covering global innovation, science and technology with a European perspective. Our dedicated team of journalists aims to educate and inspire today’s leaders by providing them with analysis and insights into the people and organisations shaping our future #SmartHealth
Published 2023-10-19 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





